Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terri Wrin

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Plos One|August 11, 2011
Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolatesSimon M Agwale, Joseph C Forbi, Frank Notka, et al.
Transactions of the American Clinical and Climatological Association|October 25, 2006
HIV evolution and escapeDouglas D Richman, Susan J Little, Davey M Smith, et al.
BMC Bioinformatics|March 21, 2014
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational methodMark C Evans, Pham Phung, Agnes C Paquet, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacityKirsten L White, Nicolas A Margot, Terri Wrin, et al.
The Journal of Infectious Diseases|February 23, 2010
Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progressionZelda Euler, Marit J van Gils, Evelien M Bunnik, et al.
Journal of Virology|June 28, 2003
Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infectionViviana Simon, Neal Padte, Deya Murray, et al.
AIDS (London, England)|June 17, 2004
The prevalence of antiretroviral drug resistance in the United StatesDouglas D Richman, Sally C Morton, Terri Wrin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2009
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruptionBecky Schweighardt, Terri Wrin, Duncan A Meiklejohn, et al.
Journal of Virology|January 15, 2010
Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressorsMarit J van Gils, Evelien M Bunnik, Judith A Burger, et al.
Retrovirology|February 4, 2016
Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodiesStefanie A Krumm, Hajer Mohammed, Khoa M Le, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Plos One|August 11, 2011
Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolatesSimon M Agwale, Joseph C Forbi, Frank Notka, et al.
Transactions of the American Clinical and Climatological Association|October 25, 2006
HIV evolution and escapeDouglas D Richman, Susan J Little, Davey M Smith, et al.
BMC Bioinformatics|March 21, 2014
Predicting HIV-1 broadly neutralizing antibody epitope networks using neutralization titers and a novel computational methodMark C Evans, Pham Phung, Agnes C Paquet, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2002
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacityKirsten L White, Nicolas A Margot, Terri Wrin, et al.
The Journal of Infectious Diseases|February 23, 2010
Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progressionZelda Euler, Marit J van Gils, Evelien M Bunnik, et al.
Journal of Virology|June 28, 2003
Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infectionViviana Simon, Neal Padte, Deya Murray, et al.
AIDS (London, England)|June 17, 2004
The prevalence of antiretroviral drug resistance in the United StatesDouglas D Richman, Sally C Morton, Terri Wrin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 14, 2009
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruptionBecky Schweighardt, Terri Wrin, Duncan A Meiklejohn, et al.
Journal of Virology|January 15, 2010
Rapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressorsMarit J van Gils, Evelien M Bunnik, Judith A Burger, et al.
Retrovirology|February 4, 2016
Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodiesStefanie A Krumm, Hajer Mohammed, Khoa M Le, et al.
Pageof 11